跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46,356 条关于
“CDK2/4/6 inhibitor”
全部
46,356
临床试验
21,404
药物
9,464
机构
2,560
资讯
12,928
6个月前
Sihuan Pharmaceutical's Bireociclib Receives NMPA Approval for First-Line HR+/HER2- Advanced Breast Cancer Treatment
5个月前
SBP Group's M701 Bispecific Antibody Receives NDA Acceptance for Malignant Ascites Treatment
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Significantly Improve Outcomes in Advanced Breast Cancer
去年
Sino Biopharm Reports Strong H1 2025 Results with 27% Growth in Innovative Drug Sales and Strategic LaNova Acquisition
11年前
Abemaciclib Shows Promise in ER+/HER2- Advanced Breast Cancer Treatment
4个月前
Avenzo Therapeutics Initiates CDK4/CDK2 Dual Inhibitor Combination Trial for HR+/HER2- Breast Cancer
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
去年
Novel CDK2 Inhibitor INX-315 Shows Promise in Overcoming Cancer Drug Resistance, Study Reveals
9个月前
Avenzo's CDK2 Inhibitor AVZO-021 Shows Promising Activity in Breast and Ovarian Cancer Patients
5个月前
Incyclix Bio Secures $5M Series B Extension to Advance CDK2 Inhibitor INX-315 in Resistant Breast and Ovarian Cancers
第 1 页,共 1293 页
上一页
下一页